Adjunctive pharmacotherapy in neonates with respiratory failure
Publication in refereed journal

香港中文大學研究人員

引用次數
替代計量分析
.

其它資訊
摘要Whereas oxygen, continuous positive airway pressure (CPAP) and mechanical ventilation are the mainstays of treatment of pulmonary conditions in newborns, there are a number of adjunctive therapies that may improve the pulmonary function of these infants. These include the use of bronchodilators and diuretics given either systemically or through the inhaled route, mucolytic agents, and anti-inflammatory agents. This chapter gives an overview of the use of the most-studied agents including aerosolized bronchodilators, systemic and inhaled diuretics, and systemic and inhaled corticosteroids in the treatment and prevention of, where appropriate, respiratory distress syndrome, bronchopulmonary dysplasia, and meconium aspiration syndrome. Evidence on the use of mucolytic agents including acetylcysteine and deoxyribonuclease, and the anti-inflammatory agents including the macrolide antibiotics, cromolyn, pentoxyfylline, and recombinant human Clara cell protein are also reviewed. (C) 2008 Published by Elsevier Ltd.
著者Fok TF
期刊名稱Seminars in Fetal and Neonatal Medicine
出版年份2009
月份2
日期1
卷號14
期次1
出版社WB Saunders
頁次49 - 55
國際標準期刊號1744-165X
語言英式英語
關鍵詞Anti-inflammatory agents; Bronchodilators; Diuretics; Mucolytic agents; Newborns
Web of Science 學科類別Pediatrics; PEDIATRICS

上次更新時間 2020-26-09 於 00:47